Literature DB >> 27876505

Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis.

Omar Abdel-Rahman1.   

Abstract

BACKGROUND: Scarce evidence exists regarding the management of squamous cell carcinoma (SCC) of the bladder. This study assessed the epidemiologic and treatment trends of SCC of the bladder.
MATERIALS AND METHODS: Cases of SCC of the bladder, diagnosed from 1973 to 2013, were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The incidence of SCC of the bladder with respect to time was assessed using the SEER United States population dataset. Relevant baseline characteristics were reported whenever available. Propensity-score matching for nonmetastatic patients receiving or not receiving radical surgery was then performed considering baseline characteristics. Survival analysis in the post-matching cohort was then evaluated using Kaplan-Meier analyses.
RESULTS: A total of 5018 patients were identified. The median age group was 70 to 75 years. The incidence of bladder SCC has decreased during the period from 1973 to 2013 (P < .05). For the post-matching cohort, there was a statistically significant difference in cancer-specific and overall survival favoring the radical surgery group compared with radiation therapy or no treatment group (P < .0001 for both endpoints). The overall survival benefit was consistent regardless of the SEER stage (localized or regional). In multivariate analysis of the matched population, radical surgery, less advanced SEER summary stage, and age less than 70 years were associated with a better overall survival.
CONCLUSION: This analysis suggests that for nonmetastatic SCC of the bladder, radical surgery achieves better outcomes compared with radiation therapy. Prospective trials to evaluate formal multimodality bladder-preserving protocols in this histologic subtype are needed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Non-urothelial; Prognosis; Squamous cell carcinoma

Mesh:

Year:  2016        PMID: 27876505     DOI: 10.1016/j.clgc.2016.10.007

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  7 in total

1.  A prognostic nomogram based on log odds of positive lymph nodes to predict the overall survival in biliary neuroendocrine neoplasms (NENs) patients after surgery.

Authors:  S Jiang; F Yang; L Zhang; X Sang; X Lu; Y Zheng; Y Xu
Journal:  J Endocrinol Invest       Date:  2022-07-30       Impact factor: 5.467

2.  The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.

Authors:  Bo-Hao Zheng; Cheng Zhang; Wen-Ze Wan; Wen-Tao Sun; Xi Cheng; Xiao-Jian Ni; Xiao-Ling Ni; Tao Suo; Han Liu; Sheng Shen; Hou-Bao Liu
Journal:  BMC Surg       Date:  2022-06-29       Impact factor: 2.030

3.  A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database.

Authors:  Benjamin W Fischer-Valuck; Jeff M Michalski; Jessika A Contreras; Randall Brenneman; John P Christodouleas; Christopher D Abraham; Eric H Kim; Vivek K Arora; Arnold D Bullock; Ruben Carmona; Robert S Figenshau; Robert Grubb; Eric M Knoche; Russell K Pachynski; Joel Picus; Bruce J Roth; Paul Sargos; Gerald L Andriole; Hiram A Gay; Brian C Baumann
Journal:  Clin Transl Radiat Oncol       Date:  2018-12-12

4.  Development and validation of a nomogram to predict the prognosis of patients with squamous cell carcinoma of the bladder.

Authors:  Mei-Di Hu; Si-Hai Chen; Yuan Liu; Ling-Hua Jia
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

Review 5.  Scoping review: bladder cancer in Nigeria - what are the gaps in clinical care and research?

Authors:  Abdulkarim Muhammad Iya; Katharina Beyer; Pinky Kotecha; Joyce Kibaru; Muzzammil Abdullahi; Sani Usman Alhassan; Muhammad Inuwa Mustapha; Abdullahi Ahmad; Yusuf Lawal; Jalo Rabiu Ibrahim; Aliyu Aminu; Aisha Abubakar; Abdullahi Saleh; Richard T Bryan; Mieke Van Hemelrijck; Beth Russell
Journal:  BMJ Open       Date:  2022-03-08       Impact factor: 2.692

6.  Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling.

Authors:  Carolyn D Hurst; Guo Cheng; Fiona M Platt; Olivia Alder; Emma Vi Black; Julie E Burns; Joanne Brown; Sunjay Jain; Jo-An Roulson; Margaret A Knowles
Journal:  J Pathol Clin Res       Date:  2022-03-14

7.  Incidence trends and survival prediction of urothelial cancer of the bladder: a population-based study.

Authors:  Hairong He; Tianjie Liu; Didi Han; Chengzhuo Li; Fengshuo Xu; Jun Lyu; Ye Gao
Journal:  World J Surg Oncol       Date:  2021-07-26       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.